Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices 13059 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10518 Application for 

Participation in the Intravenous 

Immune Globulin (IVIG) Demonstration 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: New collection (Request for a 

new OMB control number); Title of 

Information Collection: Application for 

Participation in the Intravenous 

Immune Globulin (IVIG) Demonstration; 

Use: Traditional fee-for-service (FFS) 

Medicare covers some or all 

components of home infusion services 

depending on the circumstances. By 

special statutory provision, Medicare 

Part B covers intravenous immune 

globulin (IVIG) for persons with primary 

immune deficiency disease (PIDD) who 

wish to receive the drug at home. 

However, Medicare does not separately 

pay for any services or supplies to 

administer it if the person is not 

homebound and otherwise receiving 

services under a Medicare Home Health 

episode of care. As a result, many 

beneficiaries have chosen to receive the 

drug at their doctor’s office or in an 

outpatient hospital setting. On Tuesday, 

January 3, 2012, the President signed 

into law the ‘‘Medicare IVIG Access and 

Strengthening Medicare and Repaying 

Taxpayers Act of 2012’’. The act 

authorizes a 3-year demonstration under 

Part B of Title XVIII of the Social 

Security Act to evaluate the benefits of 

providing payment for items and 

services needed for the in-home 

administration of IVIG for the treatment 

of PIDD. 

The statute limited the demonstration 

to 4,000 beneficiaries and $45 million, 

including administrative expenses for 

implementation and evaluation as well 

as benefit costs. The statute also 

required that an evaluation of the 

demonstration be conducted. Under this 

demonstration, Medicare will issue 

under Part B a bundled payment for all 

medically necessary supplies and 

services to administer IVIG in the home 

to enrolled beneficiaries who are not 

otherwise homebound and receiving 

home health care benefits. In order to 

implement the demonstration and 

ensure that statutory limits are not 

exceeded, it is necessary to positively 

enroll beneficiaries in the 

demonstration. 

This collection of information is for 

the application to participate in the 

demonstration. Participation is 

voluntary and may be terminated by the 

beneficiary at any time. Beneficiaries 

who do not participate will continue to 

be eligible to receive all of the regular 

Medicare Part B benefits that they 

would be eligible for in the absence of 

the demonstration. Form Number: 

CMS–10518 (OCN: 0938–NEW); 

Frequency: Annually; Affected Public: 

Individuals and households; Number of 

Respondents: 4,000; Total Annual 

Responses: 4,000 Total Annual Hours: 

1,000. (For policy questions regarding 

this collection contact Jody Blatt at 410– 

786–6921.) 

Dated: March 4, 2014. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2014–04998 Filed 3–6–14; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10215 and CMS– 

10416] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by April 7, 2014. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 OR, Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/Paperwork

ReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

mstockstill on DSK4VPTVN1PROD with NOTICES

13060 Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Reinstatement without change 

of a previously approved collection; 

Title of Information Collection: 

Medicaid Payment for Prescription 

Drugs—Physicians and Hospital 

Outpatient Departments Collecting and 

Submitting Drug Identifying Information 

to State Medicaid Programs; Use: In 

accordance with the Deficit Act of 2005, 

states are required to provide for the 

collection and submission of utilization 

data for certain physician-administered 

drugs in order to receive federal 

financial participation for these drugs. 

Physicians, serving as respondents to 

states, submit National Drug Code 

numbers and utilization information for 

‘‘J’’ code physician-administered drugs 

so that the states will have sufficient 

information to collect drug rebate 

dollars. Form Number: CMS–10215 

(OCN: 0938–1026); Frequency: Weekly; 

Affected Public: Private sector— 

Business or other for-profits and Notfor-profit institutions; Number of 

Respondents: 20,000; Total Annual 

Responses: 3,910,000; Total Annual 

Hours: 16,227. (For policy questions 

regarding this collection contact 

Bernadette Leeds at 410–786–9463). 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Blueprint for 

Approval of Affordable Health 

Insurance Marketplaces; Use: All states 

(including the 50 states, the territories, 

and the District of Columbia, herein 

referred to as ‘‘states’’) had the 

opportunity under Section 1311(b) of 

the Affordable Care Act to establish an 

Exchange, also known as a 

‘‘Marketplace’’, no later than October 1, 

2013 (Plan Year 2014). This current 

submission reduces the number of 

potential respondents due to various 

states electing to rely on the Federallyfacilitated Marketplace (FFM). Also, at 

the time of the original request, the tool 

was partially paper-based. During the 

intervening time, we have developed 

the on-line implementation of the tool 

and will transition all future 

applications to that system. 

States seeking to establish a 

Marketplace must build one that meets 

the requirements set out in Section 

1311(d) of the Affordable Care Act and 

45 CFR 155.105. In order to ensure that 

a State seeking approval as a State-based 

Marketplace, State-based SHOP 

Marketplace, or State Partnership 

Marketplace meet all applicable 

requirements, the Secretary will require 

a state to submit a Blueprint for 

approval and to demonstrate operational 

readiness through virtual or on-site 

readiness review. Form Number: CMS– 

10416 (OCN: 0938–1172); Frequency: 

Once; Affected Public: State, Local, or 

Tribal governments; Number of 

Respondents: 31; Number of Responses: 

31; Total Annual Hours: 5,552. (For 

policy questions regarding this 

collection, contact Sarah Summer 301– 

492–4443.) 

Dated: March 4, 2014. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2014–05000 Filed 3–6–14; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Numbers: 93.612, 93.602] 

Notice for Public Comment on the 

Adoption of Program Policies and 

Procedures for the Native Asset 

Building Initiative, a Joint Funding 

Opportunity Announcement Between 

the Administration for Native 

Americans and the Office of 

Community Services 

AGENCY: Administration for Native 

Americans, ACF, HHS. 

ACTION: Notice for Public Comment. 

SUMMARY: Pursuant to Section 814 of the 

Native American Programs Act of 1974 

(NAPA), as amended, the 

Administration for Native Americans 

(ANA) is required to provide members 

of the public an opportunity to 

comment on changes in interpretive 

rules, general statements of policy, and 

rules of agency procedure or practice 

that affect programs, projects, and 

activities authorized under the NAPA. 

In accordance with notice requirements 

of NAPA, ANA herein describes its 

planned changes to interpretive rules, 

general statements of policy, and rules 

of agency procedure or practice as they 

relate to the Fiscal Year (FY) 2014 

Funding Opportunity Announcement 

(FOA) for the Native Asset Building 

Initiative, HHS–2014–ACF–ANA–NO– 

0786 (hereinafter referred to as NABI). 

Projects funded under this initiative 

receive two grant awards from two 

Administration for Children and 

Families (ACF) Program Offices—ANA 

and the Office of Community Services 

(OCS). Grantees under the NABI 

program implement economic capacity 

building projects that are targeted 

toward increasing the economic stability 

of low-income individuals and families, 

through the establishment of Individual 

Development Accounts (IDAs) and 

related services that motivate 

individuals to save, invest, and 

accumulate assets. NABI is part of a 

national Assets for Independence (AFI) 

demonstration project, authorized under 

the Assets for Independence Act of 

1998, to test, demonstrate, and develop 

knowledge about the impact of IDAs 

and related services. For additional 

information about NABI, please see the 

Health and Human Services (HHS) 

Grants Forecast at the following link: 

http://www.acf.hhs.gov/

hhsgrantsforecast/

index.cfm?switch=grant.view&gff_

grants_forecastInfoID=66481. 

DATES: The deadline for receipt of 

comments is April 7, 2014. 

ADDRESSES: Comments in response to 

this notice should be sent via email to 

Lillian Sparks Robinson, Commissioner, 

Administration for Native Americans, at 

ANACommissioner@acf.hhs.gov. 

Comments will be available for 

inspection by members of the public at 

the Administration for Native 

Americans, 901 D Street SW., 

Washington, DC 20024. 

FOR FURTHER INFORMATION CONTACT: 

Carmelia Strickland, Director, Division 

of Program Operations, ANA, (877) 922– 

9262. 

A. Administrative Policies: ANA 

would make the following changes to 

the Administrative Policies in the NABI 

FOA. 

1. ANA will clarify the conflict of 

interest standards to ensure they align 

with the rule at 45 CFR 1336.50(f). This 

rule authorizes the Office of the Chief 

Executive of a federally recognized 

Indian tribal government to be paid 

salary and expenses with ANA grant 

funds provided such costs are related to 

a project funded under ANA FOAs and 

that the costs exclude any portion of 

salaries and expenses that are a cost of 

general government. Given this rule 

regarding the allowable use of grant 

funds, we would adopt a limited 

exception to previously published 

conflict of interest standards that 

previously did not include the 

mstockstill on DSK4VPTVN1PROD with NOTICES